www.onkologiecs.cz / Onkologie. 2023;17(1):35-39 / ONKOLOGIE 39 PŘEHLEDOVÉ ČLÁNKY Jsme v éře totální neoadjuvantní terapie u karcinomu rekta? 12. Breugom AJ, van Gijn W, Muller EW, et al. Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial. Ann Oncol. 2015;26(4):696-701. doi: 10.1093/annonc/ mdu560. Epub 2014 Dec 5. PMID: 25480874. 13. Bujko K, Glimelius B, Valentini V, et al. Postoperative chemotherapy in patients with rectal cancer receiving preoperative radio(chemo)therapy: A meta-analysis of randomized trials comparing surgery ± a fluoropyrimidine and surgery + a fluoropyrimidine ± oxaliplatin. Eur J Surg Oncol. 2015;41(6):713-23. doi: 10.1016/j.ejso.2015.03.233. Epub 2015 Apr 13. PMID: 25911110. 14. Bujko K, Glynne-Jones R, Bujko M. Does adjuvant fluoropyrimidine-based chemotherapy provide a benefit for patients with resected rectal cancer who have already received neoadjuvant radiochemotherapy? A systematic review of randomised trials. Ann Oncol. 2010;21(9):1743-1750. doi: 10.1093/annonc/mdq054. Epub 2010 Mar 15. PMID: 20231300. 15. Bahadoer RR, Dijkstra EA, van Etten B, et al. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol. 2021 Jan;22(1):29-42. doi: 10.1016/S14702045(20)30555-6. Epub 2020 Dec 7. Erratum in: Lancet Oncol. 2021;22(2):e42. PMID: 33301740. 16. Jin J, Tang Y, Hu C, et al. Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR). J Clin Oncol. 2022;40(15):1681-1692. doi: 10.1200/JCO.21.01667. Epub 2022 Mar 9. PMID: 35263150; PMCID: PMC9113208. 17. Bujko K, Wyrwicz L, Rutkowski A, et al. Long-course oxaliplatin-based preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study. Ann Oncol. 2016;27(5):834-842. doi: 10.1093/annonc/mdw062. Epub 2016 Feb 15. PMID: 26884592. 18. Ciseł B, Pietrzak L, Michalski W, et al. Long-course preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for clinical T4 and fixed clinical T3 rectal cancer: long-term results of the randomized Polish II study. Ann Oncol. 2019;30(8):1298-1303. doi: 10.1093/annonc/mdz186. PMID: 31192355. 19. Conroy T, Bosset JF, Etienne PL, et al. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(5):702-715. doi: 10.1016/ S1470-2045(21)00079-6. Epub 2021 Apr 13. PMID: 33862000. 20. Fokas E, Allgäuer M, Polat B, et al. Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12. J Clin Oncol. 2019;37(34):3212-3222. doi: 10.1200/JCO.19.00308. Epub 2019 May 31. PMID: 31150315. 21. Fokas E, Schlenska-Lange A, Polat B, et al. Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO/ARO/AIO12 Randomized Clinical Trial. JAMA Oncol. 2022;8(1):e215445. doi: 10.1001/jamaoncol.2021.5445. Epub 2022 Jan 20. PMID: 34792531; PMCID: PMC8603234. 22. Garcia-Aguilar J, Patil S, Gollub MJ, et al. Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy. J Clin Oncol. 2022;40(23):25462556. doi: 10.1200/JCO.22.00032. Epub 2022 Apr 28. PMID: 35483010; PMCID: PMC9362876. 31. MORAVSKÝ MEZIKRAJSKÝ SEMINÁŘ PRO PNEUMOLOGY 9. MORAVSKÉ PNEUMOONKOLOGICKÉ DNY 16. 17. 6. 2023 HOTEL ATOM, TŘEBÍČ VÍCE INFORMACÍ NA www.kongrespneumologie.cz Foto: Jakub Mertl
RkJQdWJsaXNoZXIy NDA4Mjc=